Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Betting On Albany International Corp. (AIN)

Page 1 of 2

Should Albany International Corp. (NYSE:AIN) investors track the following data?

In the financial world, there are many metrics shareholders can use to watch stocks. A pair of the most underrated are hedge fund and insider trading sentiment. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the top investment managers can trounce the S&P 500 by a superb amount (see just how much).

Just as key, bullish insider trading activity is a second way to look at the investments you’re interested in. As the old adage goes: there are a variety of reasons for an insider to get rid of shares of his or her company, but just one, very clear reason why they would initiate a purchase. Plenty of empirical studies have demonstrated the market-beating potential of this method if piggybackers know what to do (learn more here).

Albany International Corp. (NYSE:AIN)

Keeping this in mind, we’re going to examine the recent info surrounding Albany International Corp. (NYSE:AIN).

How are hedge funds trading Albany International Corp. (NYSE:AIN)?

At Q2’s end, a total of 12 of the hedge funds we track were bullish in this stock, a change of 33% from one quarter earlier. With the smart money’s capital changing hands, there exists an “upper tier” of notable hedge fund managers who were upping their holdings considerably.

When using filings from the hedgies we track, Chuck Royce’s Royce & Associates had the largest position in Albany International Corp. (NYSE:AIN), worth close to $15.7 million, comprising less than 0.1%% of its total 13F portfolio. Coming in second is AQR Capital Management, managed by Cliff Asness, which held a $11.4 million position; the fund has less than 0.1%% of its 13F portfolio invested in the stock. Other hedge funds that are bullish include D. E. Shaw’s D E Shaw, Jim Simons’s Renaissance Technologies and Mario Gabelli’s GAMCO Investors.

As industrywide interest increased, certain money managers have been driving this bullishness. Royce & Associates, managed by Chuck Royce, assembled the biggest position in Albany International Corp. (NYSE:AIN). Royce & Associates had 15.7 million invested in the company at the end of the quarter. Cliff Asness’s AQR Capital Management also initiated a $11.4 million position during the quarter. The other funds with brand new AIN positions are D. E. Shaw’s D E Shaw, Jim Simons’s Renaissance Technologies, and Mario Gabelli’s GAMCO Investors.

What do corporate executives and insiders think about Albany International Corp. (NYSE:AIN)?

Legal insider trading, particularly when it’s bullish, is at its handiest when the company in question has experienced transactions within the past six months. Over the latest 180-day time frame, Albany International Corp. (NYSE:AIN) has seen zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll check out the relationship between both of these indicators in other stocks similar to Albany International Corp. (NYSE:AIN). These stocks are Dixie Group Inc (NASDAQ:DXYN), Mohawk Industries, Inc. (NYSE:MHK), Culp, Inc. (NYSE:CFI), Unifi, Inc. (NYSE:UFI), and Interface, Inc. (NASDAQ:TILE). This group of stocks are the members of the textile industrial industry and their market caps match AIN’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!